Licochalcone C Induces Autophagy in Gefitinib-sensitive or-resistant Human Non-small Cell Lung Cancer Cells |
Oh, Ha-Na
(Department of Pharmacy, College of Pharmacy, Mokpo National University)
Yoon, Goo (Department of Pharmacy, College of Pharmacy, Mokpo National University) Chae, Jung-Il (Department of Dental Pharmacology, School of Dentistry, BK21 Plus, Jeonbuk National University) Shim, Jung-Hyun (Department of Pharmacy, College of Pharmacy, Mokpo National University) |
1 | Edinger, A. L. and Thompson, C. B. 2004. Death by design: Apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16, 663-669. DOI |
2 | Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C. M., Zhao, X., Christensen, J., Kosaka, T., Holmes, A. J., Rogers, A. M., Cappuzzo, F., Mok, T., Lee, C., Johnson, B. E., Cantley, L. C. and Janne, P. A. 2007. Met amplification leads to gefitinib resistance in lung cancer by activating erbb3 signaling. Science 316, 1039-1043. DOI |
3 | Filomeni, G., De Zio, D. and Cecconi, F. 2015. Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death Differ. 22, 377-388. DOI |
4 | Fung, C., Chen, X., Grandis, J. R. and Duvvuri, U. 2012. Egfr tyrosine kinase inhibition induces autophagy in cancer cells. Cancer Biol. Ther. 13, 1417-1424. DOI |
5 | Wang, P., Yuan, X., Wang, Y., Zhao, H., Sun, X. and Zheng, Q. 2015. Licochalcone c induces apoptosis via b-cell lymphoma 2 family proteins in t24 cells. Mol. Med. Rep. 12, 7623-7628. DOI |
6 | Wang, R. C. and Levine, B. 2010. Autophagy in cellular growth control. FEBS Lett. 584, 1417-1426. DOI |
7 | Zhang, X., Chen, L. X., Ouyang, L., Cheng, Y. and Liu, B. 2012. Plant natural compounds: Targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif. 45, 466-476. DOI |
8 | Wei, Y., Zou, Z., Becker, N., Anderson, M., Sumpter, R., Xiao, G., Kinch, L., Koduru, P., Christudass, C. S., Veltri, R. W., Grishin, N. V., Peyton, M., Minna, J., Bhagat, G. and Levine, B. 2013. Egfr-mediated beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 154, 1269-1284. DOI |
9 | Westover, D., Zugazagoitia, J., Cho, B. C., Lovly, C. M. and Paz-Ares, L. 2018. Mechanisms of acquired resistance to first- and second-generation egfr tyrosine kinase inhibitors. Ann. Oncol. 29, i10-i19. |
10 | Yun, C. W. and Lee, S. H. 2018. The roles of autophagy in cancer. Int. J. Mol. Sci. 19, 3466. DOI |
11 | Zheng, K., He, Z., Kitazato, K. and Wang, Y. 2019. Selective autophagy regulates cell cycle in cancer therapy. Theranostics 9, 104-125. DOI |
12 | Furusawa, J., Funakoshi-Tago, M., Mashino, T., Tago, K., Inoue, H., Sonoda, Y. and Kasahara, T. 2009. Glycyrrhiza inflata-derived chalcones, licochalcone a, licochalcone b and licochalcone d, inhibit phosphorylation of nf-kappab p65 in lps signaling pathway. Int. Immunopharmacol. 9, 499-507. DOI |
13 | Mathew, R., Karantza-Wadsworth, V. and White, E. 2007. Role of autophagy in cancer. Nat. Rev. Cancer 7, 961-967. DOI |
14 | Gorzalczany, Y., Gilad, Y., Amihai, D., Hammel, I., Sagi-Eisenberg, R. and Merimsky, O. 2011. Combining an egfr directed tyrosine kinase inhibitor with autophagy-inducing drugs: A beneficial strategy to combat non-small cell lung cancer. Cancer Lett. 310, 207-215. DOI |
15 | Jung, K. W., Won, Y. J., Oh, C. M., Kong, H. J., Lee, D. H. and Lee, K. H. 2017. Prediction of cancer incidence and mortality in Korea, 2017. Cancer Res. Treat. 49, 306-312. DOI |
16 | Kim, Y. H., Shin, E. K., Kim, D. H., Lee, H. H., Park, J. H. and Kim, J. K. 2010. Antiangiogenic effect of licochalcone a. Biochem. Pharmacol. 80, 1152-1159. DOI |
17 | Levine, B. 2007. Cell biology: Autophagy and cancer. Nature 446, 745-747. DOI |
18 | Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J. and Wang, M. 2019. P21cip1/waf1 coordinates autophagy, proliferation and apoptosis in response to metabolic stress. Cancers 11, 1112. DOI |
19 | Mathiassen, S. G., De Zio, D. and Cecconi, F. 2017. Autophagy and the cell cycle: A complex landscape. Front. Oncol. 7, 51. |
20 | Mizushima, N., Yoshimori, T. and Levine, B. 2010. Methods in mammalian autophagy research. Cell 140, 313-326. DOI |
21 | Oh, H. N., Seo, J. H., Lee, M. H., Kim, C., Kim, E., Yoon, G., Cho, S. S., Cho, Y. S., Choi, H. W., Shim, J. H. and Chae, J. I. 2018. Licochalcone c induced apoptosis in human oral squamous cell carcinoma cells by regulation of the jak2/stat3 signaling pathway. J. Cell Biochem. 119, 10118-10130. DOI |
22 | Scherz-Shouval, R. and Elazar, Z. 2011. Regulation of autophagy by ros: Physiology and pathology. Trends Biochem. Sci. 36, 30-38. DOI |
23 | Trachootham, D., Alexandre, J. and Huang, P. 2009. Targeting cancer cells by ros-mediated mechanisms: A radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579. DOI |
24 | Shin, A., Oh, C. M., Kim, B. W., Woo, H., Won, Y. J. and Lee, J. S. 2017. Lung cancer epidemiology in Korea. Cancer Res. Treat. 49, 616-626. DOI |
25 | Soria, J. C., Jang, S. J., Khuri, F. R., Hassan, K., Liu, D., Hong, W. K. and Mao, L. 2000. Overexpression of cyclin b1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60, 4000-4004. |
26 | Thomas, A., Rajan, A. and Giaccone, G. 2012. Tyrosine kinase inhibitors in lung cancer. Hematol. Oncol. Clin. North Am. 26, 589-605, viii. DOI |
27 | Thorburn, A., Thamm, D. H. and Gustafson, D. L. 2014. Autophagy and cancer therapy. Mol. Pharmacol. 85, 830-838. DOI |